HGH INVEST ApS: Financial statements 2022
CVR: 20983531
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
HGH INVEST ApS (CVR 20983531) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,313 and a net result of DKK 781,401 compared with DKK 256,419 the year before. Equity in the 2022 report amounted to DKK 4,822,007. The solvency ratio was 86.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -10,313
- Profit/Loss
- DKK 781,401
- Equity
- DKK 4,822,007
- Total Assets
- DKK 5,561,105
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -10K | 781K | 4.8M | 1 |
| 2021 | - | -8K | 256K | 4.2M | 0 |
| 2020 | - | -6K | 623K | 3.9M | - |
| 2019 | - | -6K | 242K | 2.5M | - |
| 2018 | - | -5K | 256K | 1.7M | - |
Official annual report
Keep an eye on HGH INVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of July 21, 2022, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of HGH INVEST ApS.
As of July 21, 2022, DR CPH A/S has stepped down as auditor of HGH INVEST ApS.
About HGH INVEST ApS
HGH INVEST ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1998. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Hans Gert Helsholt. The company is owned by Hans Gert Helsholt. The company has 1 employee (2020). In 2026, the company reported a gross profit of DKK -10,375 and a net result of DKK 825,728 compared with DKK 735,387 the year before. Equity in the 2026 report amounted to DKK 7,575,837.
